RLFTF · Relief Therapeutics
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Market Cap
2.818M
52 Wk Range
$0.16 - $4.88
Previous Close
$0.27
Open
$0.27
Volume
N/A
Day Range
$0.27 - $0.27
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
48.55%
Institutional Own.
18.52%
Qtr Updated
N/A
